GlassScriptPhysician profile
David C Boucher
NPI 1639174675
$4,350.56
in general payments reported to CMS, 2019-2025
49 companies · $702 in 2025
The $702 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $475 · 2021: $679 · 2022: $460 · 2023: $514 · 2024: $681 · 2025: $702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,897.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $522.14 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $357.72 | 2019-2021 | |
| Novo Nordisk INC | $330.30 | 2019-2025 | Ozempic, Wegovy |
| Pfizer INC. | $222.85 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $195.05 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $144.28 | 2019-2025 | Krystexxa, Otezla, Repatha |
| Merck Sharp & Dohme LLC | $142.76 | 2019-2024 | Dificid |
| Astellas Pharma US INC | $141.58 | 2019-2024 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $133.81 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Avanir Pharmaceuticals, INC. | $123.72 | 2019 | |
| Abbvie INC. | $120.53 | 2021-2024 | |
| Lilly USA, LLC | $118.47 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.42 | 2021-2024 | |
| Dexcom, INC. | $103.40 | 2021-2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $97.52 | 2019-2023 | Shingrix, Arexvy |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Boucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.